Featuring Spiral Laminar Flow his graft is a revolution in the treatment of Peripheral Artery Disease. SLF™ provides a real alternative to vein harvesting, reduces operating times and infection risk. The Spiral Flow Graft has been designed by clinicians, for clinicians.
TFT's research has shown that products with Spiral Laminar Flow SLF™ design, by mimicking naturally occurring three-dimensional blood flow patterns can minimise vascular occlusion following surgical intervention.
Tayside flow revolutionary (TFT) spiral laminar flow graft revolutionarises vascular grafts with its patented award winning technology.
It rewrites the standard by reintroducing natural blood flow that has been lost in the disease progression process or destroyed by standard grafts.
A real natural alternative to vein harvesting, reduces operating time and infection risk. Has the potential to reduce downstream disease progression and improve patient quality of life.
Proven high patency of 90%.
Featuring Spiral Laminar Flow Technology, which restores the natural blood flow to the artery.
The Spiral Flow bypass graft is the result of 20 years of research and development in Spiral Laminar Flow (SLF) Technology. SLF Technology reproduces the body's natural pattern of blood flow. The key clinical observation is of naturally occurring SLF in healthy human vascular systems. Over 100 publications have been written about natural blood flow and SLF providing conclusive evidence that SLF is the natural pattern for blood to flow through the body.
78% primary patency rates at 24 months in clinical trials
Viable alternative to fistula formation